QResearch

QThrombosis - risk of thrombosis

Title

Derivation and validation of the QThrombosis algorithm to predict risk of thrombosis

What is the aim of the study and why is it important?

QThrombosis is a risk prediction algorithm which calculates an individual’s risk of thrombosis taking account of their individual risk factors such as age, sex, ethnicity, clinical values and diagnoses. Ischaemic stroke is identified according to clinical codes recorded on the primary care record or the linked mortality or hospital record. The research describing the derivation and validation of the algorithm has been published in the BMJ. QThrombosis is used to quantify an individual’s risk of stroke in order to prioritise and inform decisions regarding interventions to lower risk. It is updated annually to ensure the algorithms remain calibrated to the current population since the incidence of disease and the prevalence of risk factors changes over time. The updates also enable the algorithm to take account of improvements to data quality (for example increases in the completeness of recording of risk factors such as ethnicity or laboratory values) and also allows adaptations to any changes which might be required to improve the predictive power of the tool or the population to which is applied.

Chief Investigator

Julia Hippisley-Cox

Location of research

Oxford

Date on which research approved

01-May-2011

Project reference ID

Q88

Are all data accessed are in anonymised form?

Yes

Brief summary of the dataset to be released (including any sensitive data)

Data for risk factors for thrombosis linked to diagnoses of thrombosis on GP, hospital or mortality records

Funding Source

No external funding

Research Team

Julia Hippisley-Cox, Professor Carol Coupland

Publications

  • Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study
    Authors: Hippisley-Cox J, Coupland C
    Ref: BMJ 2011;343:d4656
    https://www.bmj.com/content/343/bmj.d4656

Press Releases

Share this